ArticleOpen medicine (Warsaw, Poland)2022

EphA3 targeted by miR-3666 contributes to melanoma malignancy via activating ERK1/2 and p38 MAPK pathways.

Di Ming et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.